133 related articles for article (PubMed ID: 9785810)
1. Acute respiratory failure due to gentamicin aerosolization.
Melani AS; Di Gregorio A
Monaldi Arch Chest Dis; 1998 Jun; 53(3):274-6. PubMed ID: 9785810
[TBL] [Abstract][Full Text] [Related]
2. Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. A pilot study.
Crowther Labiris NR; Holbrook AM; Chrystyn H; Macleod SM; Newhouse MT
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1711-6. PubMed ID: 10556145
[TBL] [Abstract][Full Text] [Related]
3. Danger of polymyxin B inhalation.
Marschke G; Sarauw A
Ann Intern Med; 1971 Feb; 74(2):296-7. PubMed ID: 4322737
[No Abstract] [Full Text] [Related]
4. Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Parkins MD; Elborn JS
Expert Rev Respir Med; 2011 Oct; 5(5):609-22. PubMed ID: 21955231
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal gentamicin in treatment of bacterial meningitis.
Graybill JR; Mann J; Charache P
Johns Hopkins Med J; 1973 Jul; 133(1):51-6. PubMed ID: 4352268
[No Abstract] [Full Text] [Related]
6. Value of inhaled antibiotics in cystic fibrosis patients.
Wunderlich P; Paul KD; Wehner J
Acta Univ Carol Med (Praha); 1990; 36(1-4):34-6. PubMed ID: 2130713
[TBL] [Abstract][Full Text] [Related]
7. Aerosolized antibiotics in mechanically ventilated patients: delivery and response.
Palmer LB; Smaldone GC; Simon SR; O'Riordan TG; Cuccia A
Crit Care Med; 1998 Jan; 26(1):31-9. PubMed ID: 9428540
[TBL] [Abstract][Full Text] [Related]
8. Concentration of gentamicin in bronchial secretions of children with cystic fibrosis of tracheostomy. (Comparison between the intramuscular route, the endotracheal instillation and aerosolization).
Baran D; Dachy A; Klastersky J
Int J Clin Pharmacol Biopharm; 1975 Oct; 12(3):336-41. PubMed ID: 809371
[TBL] [Abstract][Full Text] [Related]
9. Prolonged efficiency of secondary prophylaxis with colistin aerosols for respiratory infection due to Pseudomonas aeruginosa in patients infected with human immunodeficiency virus.
Zylberberg H; Vargaftig J; Barbieux C; Pertuiset N; Rothschild C; Viard JP
Clin Infect Dis; 1996 Sep; 23(3):641-3. PubMed ID: 8879797
[No Abstract] [Full Text] [Related]
10. Aerosolized Antibiotics.
Restrepo MI; Keyt H; Reyes LF
Respir Care; 2015 Jun; 60(6):762-1; discussion 771-3. PubMed ID: 26070573
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effect of Kasugamycin on respiratory infections due to Pseudomonas aeruginosa].
Hiro Y; Doi Y
J Antibiot B; 1967 Apr; 20(2):85-9. PubMed ID: 5299330
[No Abstract] [Full Text] [Related]
12. Evaluation of target concentration intervention strategy of gentamicin therapy in a malnourished patient population of south India.
Rajendran SD; Rao YM; Karthikeyan VP
Indian J Med Res; 2005 Dec; 122(6):511-7. PubMed ID: 16518002
[TBL] [Abstract][Full Text] [Related]
13. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic approaches to chronic cystic fibrosis respiratory infections with available, emerging aerosolized antibiotics.
Ballmann M; Smyth A; Geller DE
Respir Med; 2011 Dec; 105 Suppl 2():S2-8. PubMed ID: 22208546
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis.
Scheinberg P; Shore E
Chest; 2005 Apr; 127(4):1420-6. PubMed ID: 15821224
[TBL] [Abstract][Full Text] [Related]
16. Inhaled ciprofloxacin for chronic airways infections caused by Pseudomonas aeruginosa.
Antonela Antoniu S
Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1439-46. PubMed ID: 23253321
[TBL] [Abstract][Full Text] [Related]
17. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R
Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142
[TBL] [Abstract][Full Text] [Related]
18. [Antibiotic inhalation in cystic fibrosis. A review of the literature].
Steinkamp G
Monatsschr Kinderheilkd; 1991 Feb; 139(2):73-80. PubMed ID: 1903843
[TBL] [Abstract][Full Text] [Related]
19. Nocardia cyriacigeorgica in an immunocompetent patient.
Kibe S; Meigh R; Moon T; Kastelik J; Morjaria J
Ther Adv Respir Dis; 2015 Feb; 9(1):28-30. PubMed ID: 25583961
[No Abstract] [Full Text] [Related]
20. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Greally P; Whitaker P; Peckham D
Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
